Skip to content

Effect of clofibrate in low birth weight neonates' hyperbilirubinemia

Effect of clofibrate in low birth weight neonates' hyperbilirubinemia

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT138708291162N8
Enrollment
60
Registered
2009-01-20
Start date
2006-09-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: low birth weight. Condition 2: hyperbilirubinemia. Other low birth weight Neonatal jaundice associated with preterm delivery

Interventions

Intervention 1: in cases: clofibrate 100 mg/kg once time/ day. Intervention 2: in controls: distilled water once time/ day.
Treatment - Drugs
Placebo
in cases: clofibrate 100 mg/kg once time/ day
in controls: distilled water once time/ day

Sponsors

mashhad university of medical science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 28 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:All neonates with birth weight less than 2500gr who have icter. Exclusion criteria: the presence of a hemolytic, infection, congenital anomaly or metabolic disorder and undergoing mechanical ventilation.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Decreasing of serum bilirubin. Timepoint: befor intervention and 12,24,48,72 and 96 hours after intervention. Method of measurement: measurment of serum bilirubin (diazo method).

Secondary

MeasureTime frame
Tereatment of jaundice of neonate. Timepoint: befor intervention and 24,48,72 and 96 hours after intervention. Method of measurement: decreasing of jaundice and bilirubin level in blood serum.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Ashraf mohammadzadeh

Neonatal Research Center

mohamadzadeha@mums.ac.ir , mohammadzadeh_ashraf@yahoo.com+98 51 1852 1121

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026